AU6908094A - Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule - Google Patents

Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule

Info

Publication number
AU6908094A
AU6908094A AU69080/94A AU6908094A AU6908094A AU 6908094 A AU6908094 A AU 6908094A AU 69080/94 A AU69080/94 A AU 69080/94A AU 6908094 A AU6908094 A AU 6908094A AU 6908094 A AU6908094 A AU 6908094A
Authority
AU
Australia
Prior art keywords
immunotherapy
alpha
domain
class
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69080/94A
Inventor
Mark L. Tykocinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6908094A publication Critical patent/AU6908094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
    • C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
    • C07K2319/912—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation containing a GPI (phosphatidyl-inositol glycane) anchor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU69080/94A 1993-05-05 1994-05-03 Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule Abandoned AU6908094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US057287 1987-06-02
US5728793A 1993-05-05 1993-05-05
PCT/US1994/005065 WO1994025610A1 (en) 1993-05-05 1994-05-03 Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule

Publications (1)

Publication Number Publication Date
AU6908094A true AU6908094A (en) 1994-11-21

Family

ID=22009677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69080/94A Abandoned AU6908094A (en) 1993-05-05 1994-05-03 Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule

Country Status (2)

Country Link
AU (1) AU6908094A (en)
WO (1) WO1994025610A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7010996A (en) * 1995-08-30 1997-03-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Selective elimination of t cells that recognize specific preselected targets
EP1394181A1 (en) * 2002-09-02 2004-03-03 Boehringer Ingelheim International GmbH DNA vaccine
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
JP5357782B2 (en) 2007-02-21 2013-12-04 バクシネックス インコーポレーティッド Regulation of NKT cell activity by antigen-loaded CD1d molecules
JP2012514476A (en) 2009-01-08 2012-06-28 アルバート アインシュタイン カレッジ オブ メディシン オブ イェシバ ユニバーシティ，ア ディビジョン オブ イェシバ ユニバーシティ Bacterial vaccine with cell wall-bound ceramide-like glycolipid and use thereof
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2136094T3 (en) * 1991-11-08 1999-11-16 Univ Leland Stanford Junior PEPTIDES ABLE TO JOIN CD8 MOLECULES ON CTL PRECURSORS.

Also Published As

Publication number Publication date
WO1994025610A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
AU7333494A (en) Bitetrazoleamine gas generant compositions and methods of use
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU4630493A (en) Positionable and repositionable adhesive articles
AU4705697A (en) Systems and methods for the synthesis of organic compounds
AU4886593A (en) Solvent-free organosiloxane composition and its use
AU6096594A (en) Compositions of a hydrofluorocarbon and a hydrocarbon
AU3978497A (en) Improvements in polymer compositions for chemotherapy and methods of treatment using the same
AU3249793A (en) Compositions and methods for modulating beta -amyloid
AU3220593A (en) Soluble mhc molecules and their uses
AU2371095A (en) Compositions and methods for inhibiting the binding of e-selectin or p-selectin to sialyl-lewisx or sialyl-lewisa
AU2100695A (en) Immunotherapy of cancer with allogeneic lymphocytes
AU6157396A (en) Bis-arylsulfonylaminobenzamide derivatives and the use there of as factor xa inhibitors
AU4257193A (en) Turbo compounder
AU6959694A (en) Antineoplastic compositions and methods of use
AU6485996A (en) Methods and compositions for modulation and inhibition of teomerase
AU2703197A (en) Revolving structure for display of decorative objects
AU5872294A (en) Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells
AU8123394A (en) Compositions for inhibition of intracellular transcription factors and methods therefor
AU4083997A (en) Gata-6 transcription factor: compositions and methods
AU1432595A (en) Aquatic antifouling compositions and methods
AU5487596A (en) Compositions and methods for the temporary protection of act ivated surfaces
AU2216497A (en) Novel pyruvate compounds and methods for use thereof
AU6826194A (en) 16-hydroxytriptolide composition and method for immunotherapy
AU6908094A (en) Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule